Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression

Detalles Bibliográficos
Autores principales: Noy, Ariela, Kaplan, Lawrence, Lee, Jeannette, Cesarman, Ethel, Tam, Wayne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Oral Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330038/
http://dx.doi.org/10.1186/1750-9378-7-S1-O14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3330038/
http://dx.doi.org/10.1186/1750-9378-7-S1-O14

Ejemplares similares